Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, May 30, 2014, 127 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $34.87 to $852,403,612.06.

Highlighted Stocks Traded by Insiders:

CH Robinson Worldwide (CHRW) - FREE Research Report

Freeman Angela K., who is Vice President-Human Resources at CH Robinson Worldwide, sold 600 shares at $59.73 on May 30, 2014. Following this transaction, the Vice President-Human Resources owned 32,328 shares meaning that the stake was reduced by 1.82% with the 600-share transaction.

The shares most recently traded at $59.49, down $0.24, or 0.4% since the insider transaction. Historical insider transactions for CH Robinson Worldwide go as follows:

  • 4-Week # shares bought: 400
  • 4-Week # shares sold: 100
  • 12-Week # shares bought: 400
  • 12-Week # shares sold: 100
  • 24-Week # shares bought: 400
  • 24-Week # shares sold: 100

The average volume for CH Robinson Worldwide has been 1.7 million shares per day over the past 30 days. CH Robinson Worldwide has a market cap of $8.9 billion and is part of the services sector and transportation industry. Shares are up 2.72% year-to-date as of the close of trading on Friday.

C.H. Robinson Worldwide, Inc., a third party logistics company, provides freight transportation services and logistics solutions to companies in various industries worldwide. The stock currently has a dividend yield of 2.34%. The company has a P/E ratio of 22.7. Currently, there are 2 analysts who rate CH Robinson Worldwide a buy, 5 analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CHRW - FREE

TheStreet Quant Ratings rates CH Robinson Worldwide as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full CH Robinson Worldwide Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

CareFusion (CFN) - FREE Research Report

La Fortune Gordon, who is EVP, EMEA/ANZ Commercial Ops at CareFusion, sold 2,158 shares at $42.61 on May 30, 2014. Following this transaction, the EVP, EMEA/ANZ Commercial Ops owned 18,736 shares meaning that the stake was reduced by 10.33% with the 2,158-share transaction.

The shares most recently traded at $42.79, up $0.18, or 0.42% since the insider transaction. Historical insider transactions for CareFusion go as follows:

  • 4-Week # shares sold: 1,250
  • 12-Week # shares sold: 2,500
  • 24-Week # shares sold: 69,496

The average volume for CareFusion has been 1.6 million shares per day over the past 30 days. CareFusion has a market cap of $8.9 billion and is part of the health care sector and health services industry. Shares are up 7.81% year-to-date as of the close of trading on Friday.

CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, respiratory care, and surveillance and analytics. The company has a P/E ratio of 24.0. Currently, there are 5 analysts who rate CareFusion a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CFN - FREE

TheStreet Quant Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CareFusion Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Sanderson Farms (SAFM) - FREE Research Report

Livingston Phil K, who is Director at Sanderson Farms, sold 975 shares at $91.63 on May 30, 2014. Following this transaction, the Director owned 9,970 shares meaning that the stake was reduced by 8.91% with the 975-share transaction.

The shares most recently traded at $93.26, up $1.63, or 1.74% since the insider transaction. Historical insider transactions for Sanderson Farms go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 7,155

The average volume for Sanderson Farms has been 276,000 shares per day over the past 30 days. Sanderson Farms has a market cap of $2.1 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 27.9% year-to-date as of the close of trading on Friday.

Sanderson Farms, Inc., an integrated poultry processing company, produces, processes, markets, and distributes fresh, frozen, and prepared chicken products in the United States. The stock currently has a dividend yield of 0.89%. The company has a P/E ratio of 10.8. Currently, there is 1 analyst who rates Sanderson Farms a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SAFM - FREE

TheStreet Quant Ratings rates Sanderson Farms as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Sanderson Farms Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null